Varian Launches Isolis Cryoprobe in the United States

May 17, 2023—Varian, a Siemens Healthineers company, recently announced the introduction of the Isolis cryoprobe in the United States. Isolis is a single-use, disposable device designed for use with the company’s CryoCare systems that seeks to improve procedural efficiency and precision for cryoablation. The device was granted FDA 510(k) clearance in March 2023. Clearance efforts for other target markets are ongoing, advised the company.

According to Varian, the Isolis cryoprobe provides interventional radiologists greater operational control, with features designed to enhance predictability, precision, and efficiency. It features a 2.1-mm/14-gauge shaft and a sharp probe tip to facilitate smooth and accurate placement.

The Isolis cryoprobe also offers optional integration with the Siemens Healthineers myNeedle Laser guidance system, which was developed for image-guided interventional procedures. Clinicians can use myNeedle Laser to guide the insertion and trajectory of the cryoprobe while using imaging to monitor placement progress, stated the company.

Varian’s CryoCare systems are intended for use in open, minimally invasive, or endoscopic surgical procedures in the areas of general surgery; urology; gynecology; oncology; neurology; dermatology; ear, nose, and throat; proctology; pulmonary surgery; and thoracic surgery. The systems are designed to freeze/ablate tissue by the application of extreme cold temperatures, including prostate and kidney tissue, liver metastases, tumors, skin lesions, and warts, advised the company.